Search

Search Constraints

You searched for: Author/Creator Angrilli, Francesco

Search Results

2. Chromosome 2p gain in monoclonal B‐cell lymphocytosis and in early stage chronic lymphocytic leukemia12. Issue 1 (9th October 2012)

3. Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials. (June 2016)

4. Combination of rituximab and nonpegylated liposomal doxorubicin (R‐NPLD) as front‐line therapy for aggressive non‐Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single‐center retrospective study. Issue 1 (3rd February 2017)

5. Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma. (20th November 2012)

6. Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases. Issue 9 (30th July 2018)

7. Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma. (14th May 2020)

8. Nonpeghylated liposomal doxorubicin combination regimen (R‐COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity. Issue 4 (9th July 2020)

9. Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment. (6th September 2018)

10. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O‐CLL1‐GISL study. Issue 7 (18th April 2014)